ArticleFrontiers in oncology2023

Efficacy and survival of anti-PD-1 antibody in combination with trastuzumab and chemotherapy versus trastuzumab and chemotherapy as first-line treatment of HER2-positive metastasis gastric adenocarcinoma: a retrospective study.

Ting Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.